Véronique Baud

Cancer Research · 2001–2009

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 10 researchers here, as inferred from the citation graph.

Subfields

• Cancer Research — 30 citations into it; #344 of 1,780 by trust here, #881 by citations
• Molecular Biology — 29 citations into it; #10,279 of 17,773 by trust here, #13,563 by citations
• Oncology — 21 citations into it; #270 of 1,698 by trust here, #813 by citations
• Immunology — 17 citations into it; #604 of 2,160 by trust here, #1,285 by citations

Whom Véronique Baud trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Karin
2. David L. Vaux
3. D. Hanahan
4. Wan-Wan Lin
5. Chikashi Nakanishi
6. F. Balkwill

Who trusts Véronique Baud overall

1. Hua Yu
2. T. Brummelkamp
3. M. Karin
4. G. Hotamışlıgil
5. Francis G. Spinale
6. D. Pardoll
7. Sebastian M. B. Nijman
8. J. Mcafoose
9. M. Wymann
10. R. Monteiro

Papers from Véronique Baud's perspective

Ordered by how strongly the researchers Véronique Baud trusts endorse each paper. Same corpus, a different order for every researcher.

1. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. (Cell)
2. NF-κB: linking inflammation and immunity to cancer development and progression (Nature reviews. Immunology)
3. The Hallmarks of Cancer Review
4. A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death (Science)
5. IAPs, RINGs and ubiquitylation (Nature reviews. Molecular cell biology)
6. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. (Cell)
7. Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase
8. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
9. Tumour biology: Herceptin acts as an anti-angiogenic cocktail (Nature)
10. Signal transduction by tumor necrosis factor and its relatives. (Trends in Cell Biology)

Their papers

• Is NF-κB a good target for cancer therapy? Hopes and pitfalls (2009) — 964 citations
• Signal transduction by tumor necrosis factor and its relatives. (2001) — 1,718 citations